News briefing: Ionis reads out positive data for prekallikrein-targeting drug; PPD collaborates on lupus research
In a compassionate-use pilot study for hereditary angioedema (HAE), Ionis’ PKKRx and PKK-LRx were shown to reduce the rate of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
